Omid Farokhzad

This profile gathers the share dealings of Omid Farokhzad across 3 companies, led by Seer, Inc., Cartesian Therapeutics, Inc. and Senti Biosciences Holdings, Inc. We count 44 filings; the first trade dates from 27 June 2016 and the latest from 18 February 2026.

On the open market, the record shows 2 purchases worth €201k and 16 sales worth €85.2M. Netting one side against the other leaves €85.0M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 8 share grants and 6 option exercises. Since January 2026: no purchases and 1 sale on the market.

On 19 February 2026 came the latest disclosure, an open-market sale for €41k in Seer, Inc. The latest purchase dates back some time: it was published 1,157 days ago, on 24 August 2023. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.